393 related articles for article (PubMed ID: 29735833)
1. Echinocandins: Their role in the management of
Swaminathan S; Kamat S; Pinto NA
Indian J Med Microbiol; 2018; 36(1):87-92. PubMed ID: 29735833
[TBL] [Abstract][Full Text] [Related]
2. The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.
Ghannoum M; Roilides E; Katragkou A; Petraitis V; Walsh TJ
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S618-21. PubMed ID: 26567279
[TBL] [Abstract][Full Text] [Related]
3. Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.
Marcos-Zambrano LJ; Gómez-Perosanz M; Escribano P; Zaragoza O; Bouza E; Guinea J
Antimicrob Agents Chemother; 2016 Jun; 60(6):3579-86. PubMed ID: 27021323
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates.
Walraven CJ; Bernardo SM; Wiederhold NP; Lee SA
Med Mycol; 2014 Feb; 52(2):131-139. PubMed ID: 24576999
[TBL] [Abstract][Full Text] [Related]
5. Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolates.
Shirazi F; Kontoyiannis DP
Virulence; 2015; 6(4):385-94. PubMed ID: 26065323
[TBL] [Abstract][Full Text] [Related]
6. [Activity of micafungin against Candida biofilms].
Quindós G; Villar-Vidal M; Eraso E
Rev Iberoam Micol; 2009 Mar; 26(1):49-55. PubMed ID: 19463277
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
[TBL] [Abstract][Full Text] [Related]
8. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
9. Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit.
Ghannoum MA; Chen A; Buhari M; Chandra J; Mukherjee PK; Baxa D; Golembieski A; Vazquez JA
Clin Microbiol Infect; 2009 Mar; 15(3):274-9. PubMed ID: 19210699
[TBL] [Abstract][Full Text] [Related]
10. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
[TBL] [Abstract][Full Text] [Related]
11. Comparison of susceptibility patterns using commercially available susceptibility testing methods performed on prevalent Candida spp.
Cretella D; Barber KE; King ST; Stover KR
J Med Microbiol; 2016 Dec; 65(12):1445-1451. PubMed ID: 27902377
[TBL] [Abstract][Full Text] [Related]
12. Frequency of the Paradoxical Effect Measured Using the EUCAST Procedure with Micafungin, Anidulafungin, and Caspofungin against Candida Species Isolates Causing Candidemia.
Marcos-Zambrano LJ; Escribano P; Sánchez-Carrillo C; Bouza E; Guinea J
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799221
[TBL] [Abstract][Full Text] [Related]
13. The echinocandins: three useful choices or three too many?
Bal AM
Int J Antimicrob Agents; 2010 Jan; 35(1):13-8. PubMed ID: 19942413
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation.
Prażyńska M; Bogiel T; Gospodarek-Komkowska E
Folia Microbiol (Praha); 2018 Mar; 63(2):209-216. PubMed ID: 28983822
[TBL] [Abstract][Full Text] [Related]
15. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
[TBL] [Abstract][Full Text] [Related]
16. [Adequate empiric therapy of nosocomial fungal infections in oncologic patients of intensive care units].
Mitrokhin SD; Fedankov IN; Khoteev AZh; Sokolov AA
Antibiot Khimioter; 2012; 57(3-4):40-4. PubMed ID: 22993939
[TBL] [Abstract][Full Text] [Related]
17. Lack of efficacy of echinocandins against high metabolic activity biofilms of Candida parapsilosis clinical isolates.
Thomaz DY; Melhem MSC; de Almeida Júnior JN; Benard G; Del Negro GMB
Braz J Microbiol; 2020 Sep; 51(3):1129-1133. PubMed ID: 31898245
[TBL] [Abstract][Full Text] [Related]
18. The role of micafungin and anidulafungin in the treatment of systemic fungal infections: applications and patents for two novel echinocandins.
Hinske LC; Weis F; Heyn J; Hinske P; Beiras-Fernandez A
Recent Pat Antiinfect Drug Discov; 2012 Apr; 7(1):1-7. PubMed ID: 22044354
[TBL] [Abstract][Full Text] [Related]
19. Echinocandin Resistance in Candida.
Perlin DS
Clin Infect Dis; 2015 Dec; 61 Suppl 6(Suppl 6):S612-7. PubMed ID: 26567278
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species.
Fiori B; Posteraro B; Torelli R; Tumbarello M; Perlin DS; Fadda G; Sanguinetti M
Antimicrob Agents Chemother; 2011 Jun; 55(6):3031-5. PubMed ID: 21422210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]